Llewellyns Inc Durable Medical Equipment & Medical Supplies Location: 703 Main St, Avoca, Pennsylvania 18641 Phone: (570) 457-2341 |
News Archive
Inherited mutations in voltage-gated sodium channels (Navs) are associated with many different human diseases, including genetic forms of epilepsy and chronic pain. Theodore Cummins and colleagues, at Indiana University School of Medicine, Indianapolis, have now determined the functional consequence of three such mutations.
Watson Pharmaceuticals, Inc., today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Valacyclovir Hydrochloride tablets, USP, in the 500 and 1000 mg strengths, the generic equivalent to GlaxoSmithKline, LLC's VALTREX tablets.
In popular understanding, the expression "near-death experience" refers to the transition between the states of life and death. But how should such experiences be interpreted? Are they verifiable with scientific methods? If so, how can they be explained? Attempting to relate matters of scientific knowledge to subjective experience and the realm of belief is a difficult balancing act, and has led to a variety of approaches to the topic.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
› Verified 1 days ago